These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6716226)

  • 1. Developmental pharmacokinetics of mezlocillin in newborn infants.
    Janicke DM; Rubio TT; Wirth FH; Karotkin EH; Jusko WJ
    J Pediatr; 1984 May; 104(5):773-81. PubMed ID: 6716226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental pharmacokinetics of mezlocillin in 4 newborn infants.
    Jungbluth GL; Wirth FH; Rubio TT; Janicke DM; Jusko WJ
    Dev Pharmacol Ther; 1988; 11(6):317-21. PubMed ID: 3229277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of mezlocillin in neonates.
    Chiu T; Fakhreddine F; Ayoub E
    Clin Ther; 1984; 6(5):625-35. PubMed ID: 6478469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic properties of mezlocillin in newborn infants.
    Odio C; Threlkeld N; Thomas ML; McCraken GH
    Antimicrob Agents Chemother; 1984 May; 25(5):556-9. PubMed ID: 6563875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A controlled study of the nephrotoxicity of mezlocillin and gentamicin plus ampicillin in the neonate.
    Adelman RD; Wirth F; Rubio T
    J Pediatr; 1987 Dec; 111(6 Pt 1):888-93. PubMed ID: 3316564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of infusion rate on pharmacokinetic parameters of azlocillin and mezlocillin].
    Haen E; Remien J; Richter E; Frank U; Adam D
    Arzneimittelforschung; 1985; 35(5):864-8. PubMed ID: 4026911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dose on pharmacokinetics and serum bactericidal activity of mezlocillin.
    Flaherty JF; Barriere SL; Mordenti J; Gambertoglio JG
    Antimicrob Agents Chemother; 1987 Jun; 31(6):895-8. PubMed ID: 3619421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics and dosage of mezlocillin administered by intravenous infusion].
    Modr Z; Dvorácek K; Janků I; Krebs V
    Infection; 1982; 10 Suppl 3():S191-5. PubMed ID: 6218111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics of mezlocillin. Comparison with ampicillin and influence of probenecid (author's transl)].
    Verbist L; Tjandramaga TB; Verbesselt R; de Schepper PJ
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):347-52. PubMed ID: 6460974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended-interval Dosing of Gentamicin in Premature Neonates Born at <32 Weeks' Gestation and >7 Days of age.
    Sundaram A; Alshaikh B; Dersch-Mills D; Dobry J; Akierman AR; Yusuf K
    Clin Ther; 2017 Jun; 39(6):1233-1241. PubMed ID: 28579209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation.
    Asbury WH; Darsey EH; Rose WB; Murphy JE; Buffington DE; Capers CC
    Ann Pharmacother; 1993 Apr; 27(4):490-6. PubMed ID: 8477127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of coadministration on the pharmacokinetics of mezlocillin and cefotaxime in healthy volunteers and in patients with renal failure.
    Rodondi LC; Flaherty JF; Schoenfeld P; Barriere SL; Gambertoglio JG
    Clin Pharmacol Ther; 1989 May; 45(5):527-34. PubMed ID: 2721108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HPLC study of the pharmacokinetics of mezlocillin administered by 30-minute infusion and comparison with the direct intravenous route].
    Jehl F; Peter JD; Monteil H; Dupeyron JP; Minck R
    Pathol Biol (Paris); 1984 May; 32(5):312-7. PubMed ID: 6739140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled study of the nephrotoxicity of mezlocillin and amikacin in the neonate.
    Adelman RD; Wirth F; Rubio T
    Am J Dis Child; 1987 Nov; 141(11):1175-8. PubMed ID: 3314475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics of ceftriaxone in the first three month of life].
    Rondanelli R; Regazzi MB; Stronati M; Calvi M; Lombardi G; Rondini G
    Pediatr Med Chir; 1992; 14(1):55-9. PubMed ID: 1579518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonlinear mezlocillin kinetics due to dose-dependent metabolism.
    Gundert-Remy U; Hildebrandt R; Stiehl A; Weber E
    Clin Pharmacol Ther; 1983 May; 33(5):656-62. PubMed ID: 6220858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simplified model for adjustment of gentamicin dosage in newborn infants.
    Herngren L; Broberger U; Wretlind B
    Acta Paediatr Scand; 1986 Mar; 75(2):198-204. PubMed ID: 3962654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobramycin sulfate elimination in premature infants.
    Arbeter AM; Saccar CL; Eisner S; Sarni E; Yaffe SJ
    J Pediatr; 1983 Jul; 103(1):131-5. PubMed ID: 6864378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mezlocillin in neonatal medicine].
    Sitka U; Weingärtner L; Patsch R
    Infection; 1982; 10 Suppl 3():S158-65. PubMed ID: 6218105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mezlocillin pharmacokinetics in pediatric oncology patients.
    Kramer WG; Pickering LK; Culbert S; Frankel LS
    Antimicrob Agents Chemother; 1984 Jan; 25(1):62-4. PubMed ID: 6703685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.